
Zynerba Pharmaceuticals ZYNE
Quarterly report 2023-Q2
added 08-14-2023
Zynerba Pharmaceuticals DSO Ratio 2011-2026 | ZYNE
Annual DSO Ratio Zynerba Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 14.6 K | - | 182 K | 467 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 182 K | 467 | 65.7 K |
DSO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agile Therapeutics
AGRX
|
63.1 | - | 10.11 % | $ 58.2 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
16.5 | - | 7.5 % | $ 6.35 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
71.7 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
117 | - | - | $ 754 M | ||
|
Catalent
CTLT
|
80.1 | - | - | $ 11.5 B | ||
|
DURECT Corporation
DRRX
|
100 | - | - | $ 50.1 M | ||
|
Alimera Sciences
ALIM
|
122 | - | - | $ 142 M | ||
|
Athenex
ATNX
|
89.9 | - | -23.39 % | $ 1.76 M | ||
|
Eagle Pharmaceuticals
EGRX
|
65.5 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
79.9 | - | - | $ 28.9 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
49.9 | - | - | $ 2.06 B | ||
|
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
375 | $ 3.07 | -0.65 % | $ 43.2 M | ||
|
OrganiGram Holdings
OGI
|
93 | $ 1.41 | 0.65 % | $ 402 M | ||
|
Cronos Group
CRON
|
203 | $ 2.58 | -0.19 % | $ 1.33 B | ||
|
HEXO Corp.
HEXO
|
71.3 | - | 2.45 % | $ 38.1 M | ||
|
Bausch Health Companies
BHC
|
78.9 | $ 5.66 | 0.98 % | $ 2.07 B | ||
|
Harrow Health
HROW
|
152 | $ 36.47 | 1.5 % | $ 1.34 B | ||
|
Aurora Cannabis
ACB
|
99.8 | $ 3.42 | -0.29 % | $ 86.3 M | ||
|
Canopy Growth Corporation
CGC
|
62.7 | $ 1.05 | 0.17 % | $ 113 M | ||
|
Tilray
TLRY
|
52.8 | $ 6.54 | -0.46 % | $ 4.04 B | ||
|
Neoleukin Therapeutics
NLTX
|
3.46 | - | - | $ 193 M | ||
|
Jupiter Wellness
JUPW
|
32.2 | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
83.1 | - | 1.15 % | $ 7.11 M | ||
|
Veru
VERU
|
91.5 | $ 2.36 | -1.05 % | $ 318 M | ||
|
Viatris
VTRS
|
78.8 | $ 13.62 | 1.11 % | $ 16.3 B | ||
|
Evolus
EOLS
|
62.9 | $ 4.26 | -0.14 % | $ 275 M | ||
|
Emergent BioSolutions
EBS
|
60.9 | $ 8.05 | 1.13 % | $ 412 M | ||
|
Organogenesis Holdings
ORGO
|
72.6 | $ 2.38 | - | $ 313 M | ||
|
Pacira BioSciences
PCRX
|
50.3 | $ 24.01 | 0.92 % | $ 1.11 B | ||
|
PetIQ
PETQ
|
43.1 | - | 1.64 % | $ 400 M | ||
|
ProPhase Labs
PRPH
|
111 | - | - | $ 5.07 M | ||
|
Assertio Holdings
ASRT
|
268 | $ 18.05 | 0.14 % | $ 116 M | ||
|
Radius Health
RDUS
|
16.1 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
62.7 | - | -4.76 % | $ 65.3 M | ||
|
cbdMD
YCBD
|
11.3 | $ 0.7 | 2.96 % | $ 3.02 M | ||
|
OptiNose
OPTN
|
138 | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
106 | $ 1.02 | 2.0 % | $ 50.9 M | ||
|
PLx Pharma
PLXP
|
14.1 | - | -27.8 % | $ 2.56 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
65.5 | $ 2.31 | 1.32 % | $ 2.87 M | ||
|
Zomedica Corp.
ZOM
|
31 | - | -0.21 % | $ 98 M | ||
|
Rockwell Medical
RMTI
|
43.3 | $ 0.91 | -0.07 % | $ 32.7 M | ||
|
China Pharma Holdings
CPHI
|
20.9 | $ 0.65 | 0.62 % | $ 2.79 M | ||
|
TherapeuticsMD
TXMD
|
2.3 K | $ 2.03 | -2.17 % | $ 23.5 M |